Clin2
NCT05397262Possibly a fitRecruiting

Bladder cancer treatment with radiation plus heat therapy

Bladder Cancer

Part of Cancer, Injuries & trauma, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial studies adding “heat treatment” (hyperthermia) to standard bladder cancer care using radiation, sometimes with chemotherapy. It may help the radiation work better, but your eligibility depends on cancer stage, your general health, and certain heart and metal-safety issues.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older
  • You have confirmed bladder cancer based on a biopsy/pathology report
  • Your cancer is stage M0 (no known spread to distant parts of the body)
  • Your overall functioning is good enough (ECOG 0–2)
  • You can give informed consent to join the study
  • You are able to safely receive the planned procedures (like TUR), radiation/chemoradiation, and deep pelvic heat treatment

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06586255Recruiting· Phase 1
Immunotherapy and radiation after bladder cancer surgery

This trial tests whether adding radiation therapy to immunotherapy after bladder removal surgery can help prevent cancer from coming back. It's for people with advanced bladder cancer who have already started immunotherapy.

Philadelphia, Pennsylvania
NCT07043543Not yet recruiting
Adaptive radiotherapy for bladder cancer

This trial tests a new online adaptive radiotherapy technique for bladder cancer that adjusts the radiation plan daily based on changes in the bladder. It aims to improve treatment accuracy and reduce side effects.

Dijon, Côte d'or
NCT06310369Not yet recruiting· Phase 2
Radiation therapy for BCG-resistant bladder CIS

This trial tests whether radiation therapy can help people whose bladder cancer (specifically carcinoma in situ) did not get better with BCG treatment and who are not having their bladder removed. It aims to offer a less invasive option for controlling the cancer.

NCT06364904Not yet recruiting· Phase 3
Immunotherapy plus chemo for advanced bladder cancer

This trial tests a new combination of immunotherapy (tislelizumab) plus chemotherapy (cisplatin and gemcitabine) with or without an extra drug (trilaciclib) for people with advanced bladder cancer that hasn't been treated yet. The goal is to see if this combination is safe and helps shrink tumors.

Guangzhou, Guangdong
NCT07204132Recruiting
Freezing and Immunotherapy for Bladder Cancer

This study tests a combination treatment for people with early-stage bladder cancer who want to avoid bladder removal. It uses a freezing technique (cryoablation) inside the bladder along with immunotherapy drugs to see if this can cure the cancer while keeping the bladder.

Shanghai, Shanghai Municipality
NCT03249519Recruiting
Radiation plus heat for advanced cervical cancer

This trial studies whether adding controlled heat (“hyperthermia”) to radiation therapy (or radiation with chemotherapy) can improve outcomes in advanced cervical cancer. It focuses on people who can safely receive intensive pelvic radiation and heat treatment.

Erlangen

Hear when a new Bladder Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.